These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29705007)

  • 1. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.
    Gomes FV; Edelson JR; Volk DW; Grace AA
    Schizophr Res; 2018 Nov; 201():254-260. PubMed ID: 29705007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.
    Frescura F; Stark T; Tiziani E; Di Martino S; Ruda-Kucerova J; Drago F; Ferraro L; Micale V; Beggiato S
    Pharmacol Rep; 2024 Aug; 76(4):887-894. PubMed ID: 38789891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
    Eggan SM; Hashimoto T; Lewis DA
    Arch Gen Psychiatry; 2008 Jul; 65(7):772-84. PubMed ID: 18606950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.
    Eggan SM; Lazarus MS; Stoyak SR; Volk DW; Glausier JR; Huang ZJ; Lewis DA
    Biol Psychiatry; 2012 Jan; 71(2):114-9. PubMed ID: 22036037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
    Stark T; Ruda-Kucerova J; Iannotti FA; D'Addario C; Di Marco R; Pekarik V; Drazanova E; Piscitelli F; Bari M; Babinska Z; Giurdanella G; Di Bartolomeo M; Salomone S; Sulcova A; Maccarrone M; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
    Neuropharmacology; 2019 Mar; 146():212-221. PubMed ID: 30496751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
    Gomes FV; Guimarães FS; Grace AA
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia.
    Stark T; Iannotti FA; Di Martino S; Di Bartolomeo M; Ruda-Kucerova J; Piscitelli F; Wotjak CT; D'Addario C; Drago F; Di Marzo V; Micale V
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex.
    Maćkowiak M; Bator E; Latusz J; Mordalska P; Wędzony K
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):271-89. PubMed ID: 23932495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia.
    Bilecki W; Wawrzczak-Bargieła A; Majcher-Maślanka I; Chmelova M; Maćkowiak M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.
    Volk DW; Eggan SM; Horti AG; Wong DF; Lewis DA
    Schizophr Res; 2014 Oct; 159(1):124-9. PubMed ID: 25107849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
    Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
    Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex.
    Eggan SM; Mizoguchi Y; Stoyak SR; Lewis DA
    Cereb Cortex; 2010 May; 20(5):1164-74. PubMed ID: 19703937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palatable high-energy diet decreases the expression of cannabinoid type 1 receptor messenger RNA in specific brain regions in the rat.
    Timofeeva E; Baraboi ED; Poulin AM; Richard D
    J Neuroendocrinol; 2009 Dec; 21(12):982-92. PubMed ID: 19807847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
    Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
    Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia.
    Bator E; Latusz J; Radaszkiewicz A; Wędzony K; Maćkowiak M
    Pharmacol Rep; 2015 Dec; 67(6):1124-9. PubMed ID: 26481530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    D'Addario C; Micale V; Di Bartolomeo M; Stark T; Pucci M; Sulcova A; Palazzo M; Babinska Z; Cremaschi L; Drago F; Carlo Altamura A; Maccarrone M; Dell'Osso B
    Schizophr Res; 2017 Oct; 188():132-140. PubMed ID: 28108228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
    Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
    Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia.
    Bator E; Latusz J; Wędzony K; Maćkowiak M
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):97-108. PubMed ID: 29174863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.
    Eggan SM; Stoyak SR; Verrico CD; Lewis DA
    Neuropsychopharmacology; 2010 Sep; 35(10):2060-71. PubMed ID: 20555313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
    Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
    Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.